Leukocytosis as an important risk factor for arterial thrombosis in WHO-defined early/prefibrotic myelofibrosis: An international study of 264 patients

Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification

(2011) J. Thiele et al.   BLOOD

Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients

(2011) A. Carobbio et al.   BLOOD

Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study

(2011) Tiziano Barbui et al.   JOURNAL OF CLINICAL ONCOLOGY

Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria

(2011) G Finazzi et al.   LEUKEMIA

Thrombosis in myelofibrosis: prior thrombosis is the only predictive factor and most venous events are provoked

(2010) M. A. Elliott et al.   HAEMATOLOGICA

Thrombosis in primary myelofibrosis: incidence and risk factors

(2009) T. Barbui et al.   BLOOD

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

(2009) J. W. Vardiman et al.   BLOOD

Insights into the pathogenesis and management of thrombosis in polycythemia vera and essential thrombocythemia

(2009) Alessandro M. Vannucchi   Internal and Emergency Medicine

Effect of JAK2 V617F on thrombotic risk in patients with essential thrombocythemia: measuring the uncertain

(2008) P. D. Ziakas   HAEMATOLOGICA